Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/24/26 17:20 | 6/24/26 | ARVN | Health | Drug | Pharmaceutical Preparations | Saik Andrew | CT | O | CFO | 2 | S | -157 | 9.34 | 0 | -17 | 193 | D | |||||||||||||||
6/18/26 16:06 | 6/17/26 | ARVN | Health | Drug | Pharmaceutical Preparations | Cacace Angela M | CT | O | Chief Sc | 2 | S | -116 | 9.44 | 0 | -12 | 183 | D | |||||||||||||||
5/22/26 16:15 | 5/21/26 | ARVN | Health | Drug | Pharmaceutical Preparations | Teel Randy | CT | DO | P,CEO | 2 | S | -116 | 9.77 | 0 | -12 | 287 | D | |||||||||||||||
5/13/26 16:17 | 5/11/26 | ARVN | Health | Drug | Pharmaceutical Preparations | Loomis David K | CT | O | VP,Chief | 1 | S | -19 | 9.94 | 0 | -2 | 40 | D | |||||||||||||||
5/13/26 16:16 | 5/11/26 | ARVN | Health | Drug | Pharmaceutical Preparations | Berkowitz Noah | CT | O | Chief Me | 1 | S | -110 | 9.94 | 0 | -11 | 191 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |